rainn.png
Friday May 27th, 2022 2:52AM

Pfizer to spend $11.6B on migraine treatment maker Biohaven

By The Associated Press
Related Articles
  Contact Editor

Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to venture deeper into a new treatment area.

The New York vaccine and cancer drug maker said Tuesday it will use cash on hand to buy the remaining portion of migraine treatment developer Biohaven Pharmaceutical it does not already own.

Pfizer will pay $148.50 in cash for each share of Biohaven, which makes Nurtec ODT for treating and preventing migraines and has a nasal spray under development.

Pfizer Inc. brought in more than $14 billion in sales during the recently completed first quarter from its COVID-19 vaccine Comirnaty and its new pill treatment for the virus, Paxlovid.

Most of that came from Comirnaty, which also rang up nearly $37 billion in sales last year. But revenue from Comirnaty, which Pifzer developed with BioNTech, is expected to fade in the coming years. Pfizer also faces the loss of patent protection for some key products in its broad portfolio over the next decade.

That includes Eliquis for preventing blood clots and strokes and the Prevnar 13 vaccine for preventing pneumonia and related bacterial diseases.

The company plans to have about $25 billion in sales by 2030 come from new business developments.

The deal announced Tuesday is a step in that direction. Pfizer currently has no migraine treatments. U.S. regulators approved Nurtec ODT — which stands for orally disintegrating tablet — for treating migraines in February 2020 and for preventing them about a year ago.

The drug is sold as Vydura in the European Union.

It brought in nearly $124 million in sales in the first quarter. Biohaven expects $825 to $900 million in product sales this year.

Pfizer plans to put its marketing muscle into the drug with potential launches for it in 70 countries.

Last November, Pfizer said it would invest $350 million in Biohaven to help sell Nurtec ODT and the spray, zavegepant, outside the United States.

Pfizer said Tuesday the spray is on track for U.S. acceptance in the current quarter, and an oral gel version of it also is being developed for preventing chronic migraines.

Pfizer executives told analysts they expect annual revenue from Nurtec ODT and the spray to eventually peak above $6 billion.

The pharmaceutical giant is an “ideal acquirer” of Biohaven's portfolio in part because of its strong presence in primary care, its cash position and its need for new growth drivers, Mizuho Securities USA analyst Dr. Vamil Divan said in a research note.

The deal for Biohaven also includes some other potential treatments in early stages of development.

Other elements of Biohaven’s late-stage development pipeline will go to a new, publicly traded company that keeps the Biohaven name.

The boards of both Pfizer and Biohaven have approved the sale. Biohaven shareholders, who will receive a stake in the new company, and regulators still need to ok it.

The deal is expected to close by early 2023.

Shares of Biohaven Pharmaceutical Holding Company Ltd. which is based in New Haven, Connecticut, soared almost 70% to $141.20 in midday trading.

Pfizer's stock climbed about 1% to $49.20 as broader trading indexes slipped.

___

Follow Tom Murphy on Twitter: https://twitter.com/thpmurphy

___

The story has been corrected to show that Biohaven shareholders have yet to approve the agreement.

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2022 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is spending $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own
7:31AM ( 8 minutes ago )
Putin urges stronger action to prevent wildfires
Russian President Vladimir Putin has urged authorities to take stronger action to prevent wildfires and increase coordiation between various official agencies in dealing with them
7:30AM ( 9 minutes ago )
Marcos presidency complicates US efforts to counter China
Ferdinand Marcos Jr.’s apparent landslide victory in the Philippines presidential election is giving rise to immediate concerns about a further erosion of democracy in the region, and could complicate American efforts to blunt growing Chinese influence and power in the Pacific
7:23AM ( 16 minutes ago )
Associated Press (AP)
Shanghai re-tightens on COVID, frustrating trapped residents
The city of Shanghai is doubling down on pandemic restrictions after a brief period of loosening up, frustrating residents who were hoping a more than monthlong lockdown was finally easing as the number of new cases falls in China’s largest city
6:13AM ( 1 hour ago )
With oil sales tied up, South Sudan battles to pay salaries
Many of South Sudan’s civil servants have not been paid for months as the government has run out of funds, because the income from oil exports is allocated to servicing loans until 2027
5:52AM ( 1 hour ago )
Sri Lanka anti-government protests continue despite curfew
Several hundred protesters are defying a countrywide 36-hour curfew in Sri Lanka, a day after widespread clashes left four dead and led to the prime minister's resignation
5:44AM ( 1 hour ago )
AP Business
Asian stocks follow Wall St down on rate hike, economy fears
Asian stocks have followed Wall Street lower as fears increased that U.S. rate hikes to fight inflation might stall economic growth
3:00AM ( 4 hours ago )
Court hearing: Did Biden legally suspend oil lease sales?
A federal appeals court in New Orleans hears arguments Tuesday about whether President Joe Biden legally suspended new oil and gas lease sales because of climate change worries
1:04AM ( 6 hours ago )
Sri Lankan prime minister resigns after weeks of protests
Sri Lankan Prime Minister Mahinda Rajapaksa has resigned following weeks of protests demanding that he and his brother, the president, step down over the country’s worst economic crisis in decades
10:28PM ( 9 hours ago )
AP Business - Industries
FDA restricts J&J's COVID-19 vaccine due to blood clot risk
U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots
12:29AM ( 4 days ago )
COVID coverage for all dries up even as hospital costs rise
For the first time, the U.S. came close to providing health care for all for the first time during the coronavirus pandemic
12:02AM ( 4 days ago )
Moderna Q1 profit triples on robust COVID vaccine sales
COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter
1:47PM ( 5 days ago )
AP Business - Health Care
Putin urges stronger action to prevent wildfires
Russian President Vladimir Putin has urged authorities to take stronger action to prevent wildfires and increase coordiation between various official agencies in dealing with them
7:30AM ( 9 minutes ago )
Marcos presidency complicates US efforts to counter China
Ferdinand Marcos Jr.’s apparent landslide victory in the Philippines presidential election is giving rise to immediate concerns about a further erosion of democracy in the region, and could complicate American efforts to blunt growing Chinese influence and power in the Pacific
7:23AM ( 16 minutes ago )
German FM pledges accountability for killings in Bucha
German Foreign Minister Annalena Baerbock has pledged that the international community will hold to account those responsible for the killing of civilians in the Ukrainian town of Bucha during Russia's war
7:13AM ( 26 minutes ago )
With pomp but no queen, UK govt sets out the year's agenda
Britain’s Conservative government has made sweeping promises to cut crime, improve health care and revive the pandemic-scarred economy
6:59AM ( 41 minutes ago )
Aging pope urges elderly people to consider age a blessing
Pope Francis is urging elderly people to consider their advanced aging a blessing, not a condemnation as he himself struggles to cope with a bad knee that has made walking nearly impossible
6:47AM ( 53 minutes ago )